| ￥3300 | |
| Z05971-100 | |
|
|
|
|
|
|
|
|
|
| Species | Human/Mouse/Rat | |
| Protein Construction |
|
|
| Purity | > 95% as determined by Bis-Tris PAGE | |
| Endotoxin Level | Less than 0.05 EU per μg by the LAL method. | |
| Biological Activity | Measured by its binding ability in a functional ELISA. Test result was comparable to standard batch. | |
| Expression System | E.coli | |
| Theoretical Molecular Weight | 13.51 kDa | |
| Apparent Molecular Weight | The protein migrates to 15-19 kDa based on Bis-Tris PAGE result. | |
| Formulation | Lyophilized from 0.22 μm filtered solution in PBS (pH 7.4). | |
| Reconstitution | Centrifuge the tube before opening. Reconstituting to a concentration more than 100 μg/ml is recommended. Dissolve the lyophilized protein in distilled water. | |
| Storage & Stability | Upon receiving, the product remains stable for 6 months at -20℃ or below. Upon reconstitution, the product should be stable for 3 months at -80℃. Avoid repeated freeze-thaw cycles. |
Immobilized BDNF, Human/Mouse/Rat No Tag at 1 μg/ml (100 μl/well) on the plate. Dose response curve for Human TrkB, His Tag with the EC50 of 0.39 μg/ml determined by ELISA. »
BDNF, Human/Mouse/Rat on Bis-Tris PAGE under reduced condition. The purity is greater than 95%. »
| Target Background | The brain-derived neurotrophic factor (BDNF) is a secretory growth factor that promotes neuronal proliferation and survival, synaptic plasticity and long-term potentiation in the central nervous system. Brain-derived neurotrophic factor biosynthesis and secretion are chrono-topically regulated processes at the cellular level, accounting for specific localizations and functions. |
| Synonyms | Abrineurin; BDNF; ANON2; BULN2 |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
